Telmisartan Amlodipine & Hydrochlorothiazide Tablets – A 3X way approach to achieve effective BP control in complicated cases.
SOTEL TRIO Tablets – Telmisartan 40mg + Amlodipine 5mg + Hydrochlorthiazide 12.5mg is a combination of three antihypertensive agents:
Telmisartan (an angiotensin II receptor blocker or ARB), Amlodipine (a calcium channel blocker or CCB), and Hydrochlorothiazide (a thiazide diuretic). Telmisartan blocks the effects of angiotensin II, relaxing blood vessels and lowering blood pressure. Amlodipine relaxes blood vessels by blocking calcium channels, while Hydrochlorothiazide helps reduce fluid retention by increasing urine output. This triple combination is used to treat high blood pressure (hypertension) in patients who require more than one medication to achieve adequate control.
Recommended by specialists:
✅Cardiologist: To manage Resistant hypertension
✅General physician: To treat Hypertension with comorbidities
✅Nephrologist: For Management of fluid retention
Key benefits TELMISARTAN 40 MG + AMLODIPINE 5 MG + HYDROCHLOROTHIAZIDE 12.5 MG Tablets – SOTEL TRIO :
✅Triple-Action Formula for Maximum Blood Pressure Control: Telmisartan dilates blood vessels, Amlodipine prevents calcium influx into smooth muscles, and Hydrochlorothiazide helps eliminate excess fluid.
✅Enhanced Efficacy for Resistant Hypertension: This combination is particularly effective in treating patients with resistant hypertension who do not respond adequately to monotherapy or dual therapy.
✅Comprehensive Cardiovascular and Renal Protection: Telmisartan offers heart and kidney protection, particularly in patients with diabetes or chronic kidney disease, while Hydrochlorothiazide further reduces the risk of fluid retention and heart overload.
✅Once daily dose: Provides convenient 24 hour effect with OD dose.
✅Synergistic benefits: Reduced side effects through synergy of triple components.
Indications:
✅ Resistant hypertension
✅ Hypertension with comorbidities
✅ Management of fluid retention